2021
DOI: 10.1155/2021/5233462
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of Rhizoma Drynariae Targets in the Treatment of Osteoarthritis Based on Network Pharmacology and Experimental Verification

Abstract: Rhizoma Drynariae has been widely used for the treatment of osteoarthritis (OA), but its potential targets and molecular mechanisms remain to be further explored. Targets of Rhizoma Drynariae and OA were predicted by relevant databases, and a protein-protein interaction (PPI) network was constructed to identify key targets. The Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was performed to obtain related pathways and then select significant pathways associated with OA. The OA chondrocyte m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 40 publications
0
6
0
Order By: Relevance
“…JC-1 has been widely used to detect mitochondrial membrane potential as a fluorescent probe [ 32 , 33 ]. The JC-1 dye accumulates in mitochondria in a potential-dependent manner, which is usually indicated by a shift in fluorescence emission from green (535 nm) to red (595 nm).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…JC-1 has been widely used to detect mitochondrial membrane potential as a fluorescent probe [ 32 , 33 ]. The JC-1 dye accumulates in mitochondria in a potential-dependent manner, which is usually indicated by a shift in fluorescence emission from green (535 nm) to red (595 nm).…”
Section: Discussionmentioning
confidence: 99%
“…is suggests that the GBT recipe can promote chondroprotection by inhibiting the expression of MMP-13 in inflammatory chondrocytes. JC-1 has been widely used to detect mitochondrial membrane potential as a fluorescent probe [32,33]. e JC-1 dye accumulates in mitochondria in a potential-dependent manner, which is usually indicated by a shift in fluorescence emission from green (535 nm) to red (595 nm).…”
Section: Discussionmentioning
confidence: 99%
“…16,17 Various flavonoids extracted from plants, such as quercetin, luteolin and kaempferol, are considered candidates for disease-modifying anti-OA drugs by virtue of their anti-inflammatory and chondroprotective effects. [18][19][20][21][22] Rhizoma Drynariae is the dried rhizome of Davallia mariesii T. Moore ex Baker, which has been applied in traditional Chinese medicine for thousands of years to treat joint pain, and flavonoids are the main active ingredients in Rhizoma Drynariae. 20 In previous clinical studies, it was demonstrated that oral administration of total flavonoids from Rhizoma Drynariae (TFRD) could improve Lequesne and Visual Analogue Scale (VAS) score for joint pain in patients with OA, while it could exhibit a good safety profile.…”
Section: Introductionmentioning
confidence: 99%
“…[18][19][20][21][22] Rhizoma Drynariae is the dried rhizome of Davallia mariesii T. Moore ex Baker, which has been applied in traditional Chinese medicine for thousands of years to treat joint pain, and flavonoids are the main active ingredients in Rhizoma Drynariae. 20 In previous clinical studies, it was demonstrated that oral administration of total flavonoids from Rhizoma Drynariae (TFRD) could improve Lequesne and Visual Analogue Scale (VAS) score for joint pain in patients with OA, while it could exhibit a good safety profile. 23,24 In our earlier in vitro studies, it was proved that TFRD is able to regulate the imbalance of MMPs/TIMPs caused by inflammatory factors, thus exerting a chondroprotective effect.…”
Section: Introductionmentioning
confidence: 99%
“…rough network pharmacology, researchers have revealed the mechanism of traditional Chinese medicine in the treatment of a series of rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus, and osteoarthritis [23][24][25]. is study aimed to investigate the potential mechanisms of Cibotium barometz in the treatment of OA by network pharmacology and verify them through in vitro and in vivo experiments.…”
Section: Introductionmentioning
confidence: 99%